1.98 USD
▼-0.07-3.41%
盘后 2.47 0.00%
2026-09-16
市值
$3.69M
市盈率
—
EPS
-27.18
股息率
—
52 周区间
1.50 – 29.34
成交量
85.47K
Beta
2.38
目标价
—
52W 低 1.5052W 高 29.34
价格走势
公司简介
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a...